Anchor Capital Advisors’s ResMed RMD Stock Holding History

Anchor Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$514K	Hold	2,290	–	–	0.01%	200
2025 Q4	$552K	Sell	2,290 -23	-1%	-$5.88K	0.02%	204
2025 Q3	$633K	Sell	2,313 -22	-0.9%	-$6.01K	0.02%	197
2025 Q2	$602K	Hold	2,335	–	–	0.02%	197
2025 Q1	$523K	Hold	2,335	–	–	0.02%	200
2024 Q4	$534K	Hold	2,335	–	–	0.02%	208
2024 Q3	$570K	Hold	2,335	–	–	0.02%	197
2024 Q2	$447K	Hold	2,335	–	–	0.01%	202
2024 Q1	$462K	Hold	2,335	–	–	0.01%	207
2023 Q4	$402K	Hold	2,335	–	–	0.01%	209
2023 Q3	$345K	Hold	2,335	–	–	0.01%	230
2023 Q2	$510K	Sell	2,335 -545	-19%	-$121K	0.01%	216
2023 Q1	$631K	Sell	2,880 -230	-7%	-$49.9K	0.02%	202
2022 Q4	$647K	Hold	3,110	–	–	0.02%	205
2022 Q3	$679K	Hold	3,110	–	–	0.02%	194
2022 Q2	$652K	Hold	3,110	–	–	0.02%	202
2022 Q1	$754K	Sell	3,110 -215	-6%	-$52K	0.02%	207
2021 Q4	$866K	Sell	3,325 -25	-0.7%	-$6.49K	0.02%	191
2021 Q3	$883K	Hold	3,350	–	–	0.02%	189
2021 Q2	$826K	Sell	3,350 -25	-0.7%	-$5.26K	0.02%	195
2021 Q1	$655K	Hold	3,375	–	–	0.01%	210
2020 Q4	$717K	Hold	3,375	–	–	0.02%	198
2020 Q3	$579K	Sell	3,375 -350	-9%	-$64.6K	0.01%	193
2020 Q2	$715K	Hold	3,725	–	–	0.02%	178
2020 Q1	$549K	Hold	3,725	–	–	0.02%	177
2019 Q4	$577K	Hold	3,725	–	–	0.01%	197
2019 Q3	$503K	Hold	3,725	–	–	0.02%	208
2019 Q2	$455K	Hold	3,725	–	–	0.02%	204
2019 Q1	$387	Hold	3,725	–	–	0.01%	210
2018 Q4	$424K	Hold	3,725	–	–	0.02%	221
2018 Q3	$430K	Hold	3,725	–	–	0.02%	224
2018 Q2	$386K	Hold	3,725	–	–	0.01%	236
2018 Q1	$367K	Hold	3,725	–	–	0.01%	265
2017 Q4	$315K	Hold	3,725	–	–	0.01%	234
2017 Q3	$287K	Sell	3,725 -125	-3%	-$9.56K	0.01%	234
2017 Q2	$300K	Sell	3,850 -300	-7%	-$21.5K	0.01%	233
2017 Q1	$299K	Sell	4,150 -1,000	-19%	-$69.1K	0.01%	242
2016 Q4	$320K	Hold	5,150	–	–	0.01%	239
2016 Q3	$334K	Sell	5,150 -450	-8%	-$30K	0.01%	239
2016 Q2	$354K	Hold	5,600	–	–	0.01%	237
2016 Q1	$324K	Hold	5,600	–	–	0.01%	243
2015 Q4	$301K	Hold	5,600	–	–	0.01%	253
2015 Q3	$285K	Hold	5,600	–	–	0.01%	245
2015 Q2	$316K	Hold	5,600	–	–	0.01%	250
2015 Q1	$402K	Hold	5,600	–	–	0.01%	237
2014 Q4	$314K	Hold	5,600	–	–	0.01%	269
2014 Q3	$276K	Hold	5,600	–	–	0.01%	286
2014 Q2	$284K	Hold	5,600	–	–	0.01%	286
2014 Q1	$250K	Hold	5,600	–	–	0.01%	289
2013 Q4	$264K	Sell	5,600 -56	-1%	-$2.83K	0.01%	281
2013 Q3	$299K	Buy	+5,656	New	+$274K	0.01%	267

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Anchor Capital Advisors's RMD Position: Q1 2026 in Review

Anchor Capital Advisors held its ResMed (RMD) position steady in Q1 2026 at 2,290 shares worth $514K. The position accounts for 0.01% of the portfolio, ranked #200.

Anchor Capital Advisors first reported a position in RMD in Q3 2013 and has held it in 51 quarters since. The position peaked at $883K in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Anchor Capital Advisors held 2,290 shares of ResMed worth $514K as of Q1 2026.
Anchor Capital Advisors left its ResMed share count unchanged in Q1 2026.
ResMed made up 0.01% of Anchor Capital Advisors's portfolio in Q1 2026, its #200 holding.
Anchor Capital Advisors first reported a position in ResMed in Q3 2013 and has held it in 51 quarters since.
Anchor Capital Advisors's ResMed position peaked at $883K in Q3 2021.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Anchor Capital Advisors's 13F filing for Q1 2026, filed 12 May 2026.